PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q1 EPS of ($0.51), $0.04 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $44.5 million versus the consensus estimate of $41.58 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.